Trial Profile
Phase I trial of a Parkinson's disease therapeutic administered transdermally.
Status:
Planning
Phase of Trial:
Phase I
Latest Information Update: 18 Feb 2015
Price :
$35
*
At a glance
- Drugs Antiparkinsonians (Primary)
- Indications Parkinson's disease
- Focus Adverse reactions; First in man; Pharmacokinetics
- Sponsors Corium International
- 18 Feb 2015 New trial record